Abstract
Background
Pulmonary adenoid cystic carcinoma (ACC) is a rare type of lung malignancy. The prevalence of ACC of lobar bronchial origin is lower than that of other lung malignancies, and studies investigating it are lacking. This study aimed to evaluate survival of patients with ACC of the lobar bronchus after surgical resection and to explore its prognostic factors.
Methods
Between January 2000 and December 2019, 35 patients at the National Cancer Center/Cancer Hospital with a diagnosis of ACC of the lobar bronchus were included in the retrospective analysis.
Results
During a median follow-up period of 61 months (range, 10–194 months), the analysis showed a 5-year overall survival (OS) rate of 81.4%, a 5-year locoregional recurrence-free survival rate of 84.0%, and 5-year disease-free survival rate of 60.1%. The univariate analysis exclusively identified the surgical margin as a predictor of OS, and survival was significantly longer for the patients with negative surgical margins than for those with positive surgical margins (R0 vs. R1: 94.4% vs. 66.0%; p = 0.014). Adjuvant radiotherapy was administered to most of the patients with positive surgical margins, which might have contributed to prolonged OS (R0 vs. R1+RT: 94.4% vs. 66.7%, p = 0.173; R0 vs. R1+no RT: 94.4% vs. 62.5%, p = 0.007).
Conclusions
For ACC of lobar bronchial origin, complete resection is the radical treatment, and the OS rate was significantly higher for the R0 patients than for the R1 patients. Adjuvant radiotherapy for patients with R1 may prolong survival.
Similar content being viewed by others
References
Resio BJ, Chiu AS, Hoag J, Dhanasopon AP, Blasberg JD, Boffa DJ. Primary salivary type lung cancers in the National Cancer Database. Ann Thorac Surg. 2018;105:1633–9.
Falk N, Weissferdt A, Moran CA. Primary pulmonary salivary gland-type tumors: a review and update. Adv Anat Pathol. 2015;23(1):11.
Kumar NS, Iype EM, Thomas S, Sankar UV. Adenoid cystic carcinoma of the trachea. Indian J Surg Oncol. 2016;7:62–6.
Shimizu J, Oda M, Matsumoto I, Arano Y, Ishikawa N, Minato H. Clinicopathological study of surgically treated cases of tracheobronchial adenoid cystic carcinoma. Gen Thorac Cardiovasc Surg. 2010;58:82–6.
Zhao Y, Zhao H, Fan L, Shi J. Adenoid cystic carcinoma in the bronchus behaves more aggressively than its tracheal counterpart. Ann Thorac Surg. 2013;96:1998–2004.
Wang Y, Cai S, Gao S, et al. Tracheobronchial adenoid cystic carcinoma: 50-year experience at the National Cancer Center. China Ann Thorac Surg. 2019;108:873–82.
Högerle BA, Lasitschka F, Muley T, et al. Primary adenoid cystic carcinoma of the trachea: clinical outcome of 38 patients after interdisciplinary treatment in a single institution. Radiat Oncol. 2019;14:117.
Gaissert HA, Grillo HC, Shadmehr MB, et al. Long-term survival after resection of primary adenoid cystic and squamous cell carcinoma of the trachea and carina. Ann Thorac Surg. 2004;78:1889–97.
Kumar V, Soni P, Garg M, et al. A comparative study of primary adenoid cystic and mucoepidermoid carcinoma of lung. Front Oncol. 2018;8:153.
Wo Y, Li S, Wang Y, et al. Predictors of nodal metastasis and prognostic significance of lymph node ratio and total lymph node count in tracheobronchial adenoid cystic carcinoma. Cancer Manag Res. 2018;10:5919–25.
Molina JR, Aubry MC, Lewis JE, et al. Primary salivary gland-type lung cancer: spectrum of clinical presentation, histopathologic and prognostic factors. Cancer. 2007;110:2253–9.
Benissan-Messan DZ, Merritt RE, Bazan JG, et al. National utilization of surgery and outcomes for primary tracheal cancer in the United States. Ann Thorac Surg. 2020;110:1012–22.
Nouraei SM, Middleton SE, Reza Nouraei SA, et al. Management and prognosis of primary tracheal cancer: a national analysis. Laryngoscope. 2014;124:145–50.
Honings J, van Dijck JAAM, Verhagen AFTM, van der Heijden HFM, Marres HAM. Incidence and treatment of tracheal cancer: a nationwide study in The Netherlands. Ann Surg Oncol. 2007;14:968–76.
Yang C-FJ, Shah SA, Ramakrishnan D, et al. Impact of positive margins and radiation after tracheal adenoid cystic carcinoma resection on survival. Ann Thorac Surg. 2020;109:1026–32.
Honings J, Gaissert HA, Weinberg AC, et al. Prognostic value of pathologic characteristics and resection margins in tracheal adenoid cystic carcinoma. Eur J Cardiothorac Surg. 2010;37:1438–44.
Kang D-Y, Yoon YS, Kim HK, et al. Primary salivary gland-type lung cancer: surgical outcomes. Lung Cancer. 2011;72:250–4.
Regnard JF, Fourquier P, Levasseur P. Results and prognostic factors in resections of primary tracheal tumors: a multicenter retrospective study. J Thorac Cardiovasc Surg. 1996;111:808–14.
Yusuf M, Gaskins J, Trawick E, et al. Effects of adjuvant radiation therapy on survival for patients with resected primary tracheal carcinoma: an analysis of the National Cancer Database. Jpn J Clin Oncol. 2019;49:628–38.
Xie L, Fan M, Sheets NC, Chen RC, Jiang G-L, Marks LB. The use of radiation therapy appears to improve outcome in patients with malignant primary tracheal tumors: a SEER-based analysis. Int J Radiat Oncol. 2012;84:464–70.
Chen F, Huang M, Xu Y, et al. Primary tracheal adenoid cystic carcinoma: adjuvant treatment outcome. Int J Clin Oncol. 2015;20:686–92.
Zhu F, Liu Z, Hou Y, et al. Primary salivary gland-type lung cancer: clinicopathological analysis of 88 cases from China. J Thorac Oncol. 2013;8:1578–84.
Yang H, Yao F, Tantai J, Zhao Y, Tan Q, Zhao H. Resected tracheal adenoid cystic carcinoma: improvements in outcome at a single institution. Ann Thorac Surg. 2016;101:294–300.
Je HU, Song SY, Kim DK, et al. A 10-year clinical outcome of radiotherapy as an adjuvant or definitive treatment for primary tracheal adenoid cystic carcinoma. Radiat Oncol. 2017;12:196.
Maziak DE, Todd TRJ, Keshavjee SH, Winton TL, Van Nostrand P, Pearson FG. Adenoid cystic carcinoma of the airway: thirty-two-year experience. J Thorac Cardiovasc Surg. 1996;112:1522–32.
Acknowledgment
Y Zhao analyzed the data and wrote the manuscript. GS He collected the data. YR Zhai, ZM Zhou, N Bi, YS Mao, ZF Xiao, SG Gao, JM Lv and Q Xue participated the research design and patient treatments. QF Feng edited and approved the manuscript. The authors wish to thank all the patients and their families who contributed to this research.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Disclosure
There are no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Zhao, Y., He, G., Zhai, Y. et al. Adenoid Cystic Carcinoma of Lobar Bronchial Origin: 20-Year Experience at a Single Institution. Ann Surg Oncol 29, 4408–4416 (2022). https://doi.org/10.1245/s10434-022-11590-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-022-11590-5